Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials
<strong>Background</strong> The net absolute effects of sodium-glucose co-transporter-2 (SGLT-2) inhibitors across different patient groups have not been quantified. <br> <strong>Methods</strong> We performed a meta-analysis of published large (>500 participants/arm)...
المؤلفون الرئيسيون: | Staplin, N, Roddick, AJ, Emberson, J, Reith, C, Riding, A, Wonnacott, A, Kuverji, A, Bhandari, S, Baigent, C, Haynes, R, Herrington, WG |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Elsevier
2021
|
مواد مشابهة
-
Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials
حسب: Natalie Staplin, PhD, وآخرون
منشور في: (2021-11-01) -
Impact of diabetes on the effects of sodium glucose co-transporter-2 (SGLT2) inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
حسب: Herrington, W, وآخرون
منشور في: (2022) -
UK Kidney Association clinical practice guideline: sodium-glucose co-transporter-2 (sglt-2) inhibition in adults with kidney disease 2023 update
حسب: Roddick, AJ, وآخرون
منشور في: (2023) -
UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE
حسب: Alistair J. Roddick, وآخرون
منشور في: (2023-10-01) -
Cardiac, renal, and metabolic effects of sodium–glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium–glucose co-transporter 2 inhibitors
حسب: Herrington, WG, وآخرون
منشور في: (2021)